Skip to main content

Table 1 Baseline characteristics of NSTE-ACS patient and control groups

From: Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome

 

NSTE-ACS group

n = 212

Control group

n = 60

P

Age, years

Male gender, n (%)

Smoking, n (%)

Hypertension, n (%)

Diabetes, n (%)

BMI, kg/m2

Cr, umol/L

TC, mmol/L

TG, mmol/L

HDL-C, mmol/L

LDL-C, mmol/L

hs-CRP, mg/L#

NLR#

Admission GRACE score

Discharge GRACE score

Cys-C, mg/L

64.23 ± 14.34

133 (62.74)

75 (35.38)

105 (49.53)

40 (18.87)

25.35 ± 5.36

65.59 ± 14.78

4.53 ± 1.25

1.44 ± 0.85

1.23 ± 0.32

3.29 ± 0.99

10.40 (6.63,26.20)

5.03 (3.47,9.56)

143.74 ± 44.94

111.32 ± 30.78

0.94 ± 0.28

63.64 ± 8.01

37 (61.67)

20 (33.33)

29 (48.33)

15 (25.00)

24.33 ± 2.81

63.53 ± 17.74

4.51 ± 1.08

1.37 ± 0.64

1.27 ± 0.22

3.07 ± 0.66

0.47 (0.16,0.85)

1.45 (1.21,1.92)

-

-

0.76 ± 0.12

0.83

0.88

0.77

0.87

0.30

0.40

0.57

0.95

0.67

0.46

0.25

0.00 *

0.00 *

-

-

0.00*

  1. Value are mean ± SD except where expressed as median (quartile 1, quartile 3)#. *P < 0.05 compared to control group. NSTE-ACS Non-ST-elevation acute coronary syndrome; BMI Body mass index; TC Total plasma cholesterol; TG Triglycerides; HDL-C High density lipoprotein cholesterol; LDL-C Low density lipoprotein cholesterol; hsCRP High-sensitivity C-reactive protein; NLR Neutrophil to lymphocyte ratio; GRACE Global registry of acute coronary events; Cys-c Cystatin c